drugset / Trial / NCT00002923
KRN5500 in Treating Patients With Metastatic Solid Tumors
Phase 1
Completed
27 enrolled
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to evaluate the effectiveness of KRN5500 in treating patients with metastatic solid tumors.
Timeline
- Start
- 1997-05
- Primary completion
- 2000-01
- Completion
- 2000-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KRN5500 | Small molecule | — | Intravenous |